Dorma Home About Pipeline Markets Services Contact Targ Research Pre-Clinical IND DT-320 DT-320 Indication(s): Breast, Bladder, and Pancreatic Cancer Patent: US Pending Description A small MW compound found in diversity chemical library screen. Testing currently underway has selective kill against s...

Dorma Home About Pipeline Markets Services Contact Targ Address: DormaTarg, Inc. 940 SL Young Blvd, Suite 118 Oklahoma City, Oklahoma 73104-5020 Email: Address DormaTarg, Inc. 940 SL Young Blvd, Suite 118 Oklahoma City, Oklahoma 73104-5020 News Sep. 1, 2012 - DormaTarg awarded SBIR Phase I Grant for...

Dorma Home About Pipeline Markets Services Contact Targ 9/12/12 - DormaTarg Awarded SBIR Phase I Grant for $296,937 Dr. Paul Hauser is the Principal Investigator for this particular grant entitled "Identifying the drug target in dormant cancer cells." 11/1/11 - DormaTarg awarded SBIR Phase II Grant ...

Dorma Home About Pipeline Markets Services Contact Targ Drug Discovery Services DormaTarg offers the experience of biochemists and cancer cell biologists to develop relevant high-throughput microplate bioassays for lead compound identification. We also offer libraries of drug-like molecules with hig...

Dorma Home About Pipeline Markets Services Contact Targ Bladder cancer occurs in about 63,000 Americans per year and kills about 12,000. Some bladder cancers are highly aggressive whereas others are indolent but tend to recur. Bladder Cancer Our research is aimed at understanding how the complex int...